Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Curaleaf Holdings Inc
(OP:
CURLF
)
1.710
-0.030 (-1.72%)
Streaming Delayed Price
Updated: 3:58 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Curaleaf Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
Why Cannabis Sales Are Down In Massachusetts And New Mexico: The Numbers Behind The Dip
Today 14:40 EST
Massachusetts' average revenue per dispensary dropped to $362k/month, down 8% year-over-year, in New Mexico sales went down 3% in November.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil
December 06, 2024
While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Illinois Cannabis Sales Back On Track In October Hitting $142.3M After Slight September Dip
December 06, 2024
ollowing a drop in September cannabis sales numbers in Illinois, October figures totaled $142.3 million, a 4.2% increase sequentially, reported New Cannabis Ventures' Alan Brochstein. Cannabis sales...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season
December 05, 2024
Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles.
Via
Benzinga
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
December 05, 2024
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Grön Launches New Edibles Flavors Across Curaleaf Dispensaries In Arizona
December 03, 2024
Via
Benzinga
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
December 04, 2024
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
December 03, 2024
Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Cuts Opioid Prescriptions By 53%, Utah Study Suggests
December 02, 2024
Discover how cannabis for pain management reduced opioid prescriptions by 53% in Utah, signaling new opportunities for medical markets.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From November 29, 2024
November 29, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Pharma-Grade Cannabis Could Hit Walgreens & CVS—But Can The Industry Survive The FDA?
November 28, 2024
As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewal
November 27, 2024
Via
Benzinga
Federal Policy Could Add $3 Billion To Cannabis Industry: On Track To Reach $55 Billion By 2030
November 26, 2024
According to LeafLink, over the next 2-3 years, 5,000 non-MSO retailers are projected to open in key states, increasing store counts by 70%.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?
November 22, 2024
According to Z&A, its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x.
Via
Benzinga
Best And Worst Performing States For Cannabis Sales In 2024: YTD Winners & Losers
November 21, 2024
BDSA's October 2024 data highlights Maryland as the fastest-growing state for cannabis sales, with a year-to-date increase of 57.8%.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
November 21, 2024
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
Via
Benzinga
Topics
Cannabis
ETFs
Government
Exposures
Cannabis
Political
Curaleaf Secures First Marijuana Research License In Massachusetts
November 18, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Can Trump's Return Save The Cannabis Sector? Debt Mounts As Giants Face Post-Election Reckoning
November 18, 2024
The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Trump Wants Matt Gaetz Confirmed '100%,' So Does The Cannabis Industry
November 18, 2024
Trump's nomination of Gaetz for Attorney General has stirred controversy and sparked doubts due to his past controversies and inconsistent stance on cannabis.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores
November 15, 2024
RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Flora Growth Quarterly Revenue Falls 28% YoY As Expenses Rise
November 15, 2024
Via
Benzinga
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
November 13, 2024
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
November 08, 2024
Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Hemp Market Surge: How New Regulations Could Impact Growth
November 08, 2024
Hemp industry regulatory changes in 2024 may impact delta-8 THC sales, spark market shifts, and intensify hemp vs. marijuana sector conflicts.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Curaleaf Q3 Report: 3% Increase In EBITDA And 9% Decrease In Net Loss
November 08, 2024
Curaleaf Holdings, Inc. reported its financial and operating results for the third quarter.
Via
Talk Markets
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
November 06, 2024
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors?
November 06, 2024
The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million.
Via
Benzinga
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
November 06, 2024
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit
November 06, 2024
Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
North Dakotans Reject Measure To Legalize Recreational Cannabis, 'Keeping A Shadow Over Their Garden'
November 06, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.